Author:
Andreeva T.A.,Zharkov P.A.,Zozulya N.I.,Zorenko V.Y.,Konstantinova V.N.,Lavrentieva I.N.,Davydkin I.L.,Petrov V.Y.,Polyanskaya T.Yu.,Soldatenkov V.E.,Shutov S.A.
Publisher
Media Sphere Publishing Group
Reference55 articles.
1. WFH Guidelines for the Management of Hemophilia, 3rd edition
2. Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies
3. Castaman G, Santagostino E, Kremer Hovinga J, Schutgens R, Robson S, Meier O, Jiménez-Yuste V. Surgical Experience from the Phase III STASEY Trial of Emicizumab Prophylaxis in Persons with Hemophilia A (PwHA) with FVIII Inhibitors: Data from the Second Interim Analysis [abstract]. Res Pract Thromb Haemost. 2020;4(suppl 1)
4. Buckner TW, Carpenter SL, Daoud N, Lattimore SU, Lee L, McLean T, Morton P, Recht M. Surgeries and procedures in people with haemophilia A on emicizumab prophylaxis: analysis from the ATHN 7 haemophilia natural history study. The European Association for Haemophilia and Allied Disorders (EAHAD) Annual Meeting. 2023;PO166
5. Real‐world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures